Stephen Hecht
5Patents
3h-index
11Co-inventors
54Inventor score
Filing activity: Jan 15, 1988 → Jan 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5114969A | Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same | Human Necessities | 66 | Expired |
| US5231209A | Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same | Human Necessities | 63 | Expired |
| US4923813A | Monoclonal antibody-based immunoassay for cyclic DNA adducts resulting from exposure to crotonaldehyde or acrolein | Emerging Cross-Sectional Technologies | 7 | Expired |
| US10624943B2 | Kava derived therapeutic compounds and methods of use thereof | Human Necessities | 1 | Active |
| US10918687B2 | Kava derived therapeutic compounds and methods of use thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.